Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 24 of 30

Page 24 of 30 – SEC Filing



(c)	Number of Shares as to which person has:

	(i)	Sole power to vote or to direct vote:

		1,310,494

	(ii)	Shared power to vote or to direct vote:

		None

	(iii)	Sole power to dispose or direct disposition of:

		1,310,494

	(iv)	Shared power to dispose or to direct disposition of:

		None

AFT MASTER

(a)	Amount Beneficially Owned:

		465,000

(b)	Percent of Class:

		2.17%

(c)	Number of Shares as to which person has:

	(i)	Sole power to vote or to direct vote:

		465,000

	(ii)	Shared power to vote or to direct vote:

		None

	(iii)	Sole power to dispose or direct disposition of:

		465,000

	(iv)	Shared power to dispose or to direct disposition of:

		None

Page 24 of 30 Pages

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 24 of 30